Definium Therapeutics, Inc. (DFTX) stock

DFTXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/30

$32.08−0.92 (-2.79%)

Close on Nov 13, 2026Market cap $4.31BP/E –Yield –

Definium Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

Definium Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?